With drug pricing controls back on the legislative table in the US, the influential Institute for Clinical and Economic Review (ICER) has published its third report on "unsupported" price increases – ...
Findings from Spherix Global Insights’ refresh of Market Dynamix™: Rheumatoid Arthritis (US) 2026, based on a survey of 103 U.S. rheumatologists conducted July 30 through August 5, show physician ...
President Trump has been promoting new data showing U.S. prescription drug prices fell 0.8% in July and are down 3.1% from a ...
Detailed price information for Apogee Therapeutics Inc (APGE-Q) from The Globe and Mail including charting and trades.
AbbVie said on Thursday its therapy for a type of blood cancer has met the main goals of a late-stage trial. The therapy ...
AbbVie Inc. (NYSE:ABBV)’s experimental blood-cancer therapy etentamig delivered positive results in a late-stage trial for ...
24d
Drug prices have declined sharply, and Trump is taking credit. The reason behind the drop is complex
President Donald Trump has been promoting new data showing U.S. prescription drug prices fell 0.8% in July and are down 3.1% ...
Entyvio is a biologic medicine approved for the treatment of adults with moderately to severely active ulcerative colitis and Crohn’s disease.
Sept 1 (Reuters) - U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical companies in a ...
RBC Capital Markets analyst Trung Huynh downgrades shares of the Keytruda maker following a nearly 13% rally.
The U.S. FDA has approved Johnson & Johnson's autoimmune disease treatment Stelara for pediatric ulcerative colitis patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results